New insights into the treatment of gastroesophageal reflux disease

Bibliography

• FOUAD YM, KATZ PO, HATLEBAKK JG, CASTELL DO: Ineffective oesophageal motility: the most common motility abnormality in patients with GERD- associated respiratory symptoms. Am.j Gastroenterol (1999) 94:1464–1467.
   PubMed Web of Science ®Google Scholar
• DE VAULT KR, CASTELL DO: Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am. Gastroenterol (1999) 94:1434–1442.
   PubMedGoogle Scholar
• CUNNINGHAM KM, HOROWITZ M, RIDDEL PS et al.: Relation among autonomic nerve dysfunction, oesophageal motility, and gastric emptying in gastro-esophageal reflux disease. Gut (1991) 32:1436–1440.
   PubMed Web of Science ®Google Scholar
• DODDS WJ, DENT J, HOGAN WJ, HELM JF et al.: Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl. I Med. (1982) 307:1547–1552.
   PubMed Web of Science ®Google Scholar
• DENT J, HOLLOWAY RH, TOOLI J, DODDS WJ: Mechanisms of lower oesophageal incompetence in patients with symptomatic gastroesophageal reflux. Gut (1988) 29:1020–1028.
   PubMed Web of Science ®Google Scholar
• MITTAL RK, FISHER M: Electrical and mechanical inhibition of crural diaphragm during transient relaxation of the lower oesophageal sphincter. Gastroenterology (1990) 99:1208–1212.
   Google Scholar
• HOLLOWAY RH, PENAGINI R, IRELAND AC: Criteria for objective definition of transient lower oesophageal sphincter relaxation. Am. J. Physiol (1995) 268:G128–33.
   PubMed Web of Science ®Google Scholar
• MITTAL RK, MCCALLUM RW: Characteristics and frequency of transient relaxations of the lower oesophageal sphincter in patients with reflux oesophagitis. Gastroenterology (1988) 95:593–599.
   PubMed Web of Science ®Google Scholar
• MITTAL RK, HOLLOWAY RH, PENAGINI R et al.: Transient lower oesophageal sphincter relaxation. Gastroenterology (1995) 109:601–610.
   PubMed Web of Science ®Google Scholar
• •An overview of transient lower oesophageal sphincter relaxation.
   Google Scholar
• KAHRILAS PJ, LIN S, CHEN J, MANKA M: The effect of hiatus hernia on gastro-esophageal junction pressure. Gut (1999) 44:476–482.
   PubMed Web of Science ®Google Scholar
• KAHRILAS PJ, MANAKA M, JOEHL RJ: Increased frequency of transient lower oesophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology (2000) 118:688–695.
   PubMedGoogle Scholar
• ••Reports the significance of TLESRs inpatients with hiatal hernia.
   Google Scholar
• KATZ PO, CASTELL DO: GERD during pregnancy. Gastroenterol Clio. North. Am. (1998) 27:153–167.
   PubMedGoogle Scholar
• MITTAL RK, ROCHESTER DF, MCCALLUM RW et al: Human lower oesophageal sphincter pressure response to increased intra-abdominal pressure. Am. Physiol (1990) 21:G624–G630.
   Google Scholar
• PIMENTEL M, ROSSI F, CHOW EJ et al: Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux. j. Cl/n. Gastroenterol (2002) 34:221–224.
   PubMed Web of Science ®Google Scholar
• MARSHALL RE, ANGGIANSAH A, MANIFOLD DK et al: Effect of omeprazole 20 mg twice daily on duodenogastric and gastroesophageal bile reflux in Barrett's oesophagus. Gut (1998) 43:603–606.
   PubMed Web of Science ®Google Scholar
• LANAS A, SANTOLARIA S: Gastroesophageal reflux disease (GERD): current agents and future perspective. Curi: Pharm. Des. (2001) 7:1–18.
   PubMedGoogle Scholar
• STEIN H, DE MEESTER T, HINDER R: Outpatient physiological testing and surgical management of foregut motor disorders. Carr: Pro& Surg. (1992) 24:415–455.
   Google Scholar
• BOWERY NG, PRATT GD: GABAB receptors as targets for drug action. Arzneimittel Forschung (1992) 42:215–223.
   PubMed Web of Science ®Google Scholar
• GRIDER JR, FOXX-ORENSTEIN AE, JIN JG: 5-hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology (1998)115:370–380.
   PubMed Web of Science ®Google Scholar
• BLACKSHOW LA: Gastro-oesophageal afferent and serotonergic inputs to vagal efferent neurones. 1. Amon. Nerv. Syst. (1994) 49:93–103.
   Google Scholar
• MATHIAS CJ: The classification and nomenclature of autonomic disorders - ending chaos, resolving conflict and hopefully achieving clarity. Clin. Amon. Res. (1995) 5:C307–310.
   Google Scholar
• MATHIAS CJ: Autonomic disorders and their recognition. N Engl. J. Med. (1997) 336:721–724.
   PubMed Web of Science ®Google Scholar
• CAMILLERI M, FORD MJ: Functional gastrointestinal disease and the autonomic nervous system: a way ahead? Gastroenterology (1994) 106:1114–1118.
   PubMed Web of Science ®Google Scholar
• CAMILLERI M: Neurogastroenterology: evolving concepts and tecniques to study motility and hypersensitivity. Digest. Liver Dis. (2000) 32 (Supp1.3):227–232.
   Google Scholar
• •An overview of new concepts in neurogastroenterology.
   Google Scholar
• POLTRAS P: Motilin. In: Gut peptides: Biochemistry and PhysiologyWalsh JH, Dockray QI(Eds), Raven press Ltd, New York (1994):261–304.
   Google Scholar
• BIANCANI P, BARWICK K, SELLING J, MCCALLUM R: Effects of acute experimental oesophagitis on mechanical properties of the lower oesophageal sphincter. Gastroenterology (1984) 87:8–16.
   PubMedGoogle Scholar
• SALAPATEK AMF, DIAMANT NE: Assessment of neural inhibition of the lower oesophageal sphincter in cats with oesophagitis. Gastroenterology (1993) 104:810–818.
   PubMedGoogle Scholar
• EASTWOOD GL, BECK BD, CASTELL DO et al.: Beneficial effect of indomethacin on acid-induced oesophagitis in cats. Dig. Dis. Sci. (1981) 26:601–608.
   PubMed Web of Science ®Google Scholar
• STEWART IM, HOSKING DJ, PRESTON BJ et al.: Oesophageal motor changes in diabetes mellitus. Thorax (1976) 31:278–283.
   PubMed Web of Science ®Google Scholar
• HEATLEY RV, COLLINS RJ, JAMES PD et al.: Vagal function in relation to gastro-esophageal reflux and associated motility changes. Br. Med. J. (1980) 280:755–757.
   PubMedGoogle Scholar
• CHAKRABORTY TK, OGILVIA AL, HEADING RC, EWING DJ: Abnormal cardiovascular reflexes in patients with gastro-oesophageal reflux. Gut (1989) 30:46–49.
   PubMed Web of Science ®Google Scholar
• BHARUCHA AE, CAMILLERI M, LOW PA et al.: Autonomic dysfunction in gastrointestinal motility disorders. Gut (1993) 34:397–401.
   PubMed Web of Science ®Google Scholar
• RICHARDS WG, SUGARBAKER DJ: Neuronal control of oesophageal function. Chest Surg. Clin. N. Am. (1995) 5:157–171.
   PubMedGoogle Scholar
• CAMPO SMA, CAPRIA A, ANTONUCC IF et al: Decreased sympathetic inhibition in gastroesophageal reflux disease. Clin. Amon. Res. (2001) 11:45–51.
   Google Scholar
• •A new hypothesis of sympathetic defective neural control in GERD.
   Google Scholar
• DENT J, BRUN J, FENDRICK AM et al: On behalf of the Genval Workshop Group. An evidence-based appraisal of reflux disease management-The Genval Workshop report. Gut (1999) 44:S1–S16.
   Google Scholar
• DE VAULT KR, CASTELL DO: Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am. 1. Gastroenterol (1999) 94:1434–1442.
   PubMedGoogle Scholar
• ••An overview of the guidelines for diagnosisand treatment of GERD.
   Google Scholar
• DENT J: Management of reflux disease. Gut (2002) 50:iv67-iv71.
   Google Scholar
• DENT J, JONES R, TALLEY NJ: Management of gastro-esophageal reflux disease in general practice. B. M.1 (2001) 322:344–347.
   PubMed Web of Science ®Google Scholar
• ••A practical report detailing the managementof GERD.
   Google Scholar
• PALMER RH, FRANK WO, ROCKHOLD FW: Cimetidine 800 mg twice daily for healing erosions and ulcerations in gastroesophageal reflux disease. Gastroenterology (1990) 12:S29–S34.
   Google Scholar
• SIMON TJ, BERENSON MM, BERLIN RG et al: Randomized, placebo-controlled comparison of famotidine 20 mg b.i.d. in patients with erosive oesophagitis. Aliment. Pharmacol The]: (1994) 8:71–79.
   Google Scholar
• ALBIBI R, MCCALLUM RW: Metoclopramide: pharmacology and clinical application. Ann. Intern. Med (1983) 98:86–95.
   PubMed Web of Science ®Google Scholar
• WEIHRAUCH TR, FORSTER CE KRIEGLSTEIN J: Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry. Postgrad. Med. J. (1979) 55 (Suppl .1):7–10.
   Google Scholar
• WEINBECK M, LI Q: Cisapride in gastroesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH. Scand. Gastroenterol Sapp]. (1989) 165:13–18.
   Google Scholar
• RAMPE D,ROY ML, DENNIS A et al: A mechanism for the proarrythmic effects of cisapride: high affinity blockade of the human cardiac potassium channel HERG FEBS. Lett. (1997) 417:28–32.
   Google Scholar
• VIGNERI S, TERMINI R, PILOTTO A: A comparison of five maintenance therapies for reflux oesophagitis. N Engl. I Med. (1995) 333:1106–1110.
   PubMed Web of Science ®Google Scholar
• ••Maintenance treatment for GERD.
   Google Scholar
• LAMBERT R: Current practice and future perspectives in the management of gastroesophageal reflux disease. Aliment. Pharmacol Ther. (1997) 11:651–662.
   PubMedGoogle Scholar
• GALMICHE JP, BARTHELEMY P, HAMELIN B: Treating the symptoms of gastroesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment. Pharmacol Ther. (1997) 11:765–773.
   PubMed Web of Science ®Google Scholar
• KROMER W, KRUGER U, HUBER R et al.: Differences in pH-dependent activation rates of substituted benzimidazoles and biological M vitro correlates. Pharmacology (1998) 56:57–70.
   PubMed Web of Science ®Google Scholar
• KROMER W, HORBACH S, LUHMANN R et al.: Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis. Pharmacology (1999) 59:57–77.
   PubMed Web of Science ®Google Scholar
• ROBINSON M: New innovation in acid suppression: review of the proton pump inhibitors rabeprazole and pantoprazole. Practical Gastroenterol (1999) Supp1:1–20.
   Google Scholar
• LANGTRY HD, WILDE MI: Lansoprazole:an update of its pharmacological properties and clinical efficacy in the management of acid-related disorders. Drugs (1997) 54:473–500.
   PubMed Web of Science ®Google Scholar
• BARDHAN KD, MORRIS P, THOMPSON M et al: Omeprazole in the treatment of erosive oesophagitis refractory to high-dose cimetidine and ranitidine. Gut (1990) 31:745–749.
   PubMed Web of Science ®Google Scholar
• JOHNSSON F, WEYWADT L, SOLHAUG J et al.: One-week omeprazole treatment in the diagnosis of gastroesophageal reflux disease. Scand. Gastroenterol (1998) 33:20–24.
   Google Scholar
• FASS R, FENNERTY MB, OFFMAN JJ et al.: The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology (1998) 115:42–49.
   PubMed Web of Science ®Google Scholar
• ••Value of the PPI test in non-cardiac chestpain due to GERD.
   Google Scholar
• LIND T, RYDBERG L, KYLEBACK A et al.: Esomeprazole provides improved acid control versus omeprazole in patients with symptoms of gastroesophageal reflux disease. Aliment. Pharmacol The]: (2000) 14:861–867.
   PubMed Web of Science ®Google Scholar
• TYTGAT GNJ: Long-term therapy for reflux oesophagitis. N Engl. I Med. (1995) 333:1148–1150.
   PubMedGoogle Scholar
• •Long-term therapy for oesophagitis.
   Google Scholar
• LUNDELL I: The knife or the pill in the long-term treatment of gastroesophageal reflux disease. Yale j Biol. Med. (1994) 67:233–238.
   PubMedGoogle Scholar
• LUNDELL I: New information relevant to long-term management of endoscopy-negative reflux disease. Aliment. Pharmacol Thei: (1997) 11:93–98.
   Google Scholar
• KLINKENBERG-KNOL EC, NELIS F, DENT J et al.: Long-term omeprazole treatment in resistant gastroesophageal reflux disease, efficacy, safety and influence on gastric mucosa. Gastroenterology (2000) 118:661–669.
   PubMed Web of Science ®Google Scholar
• SHIRAZI SS, SCULZE K, SOPER RT: Long-term follow-up for treatment of complicated chronic reflux oesophagitis. Arch. Sorg. (1987) 122:548–552.
   PubMedGoogle Scholar
• LUOSTARINEN M, ISOALURI J, LAITINER J et al.: Fate of Nissen fundoplication after 20 years. A clinical, endoscopical, and functional analysis. Gut (1993) 34:1015–1020.
   Google Scholar
• BRAND DL, EASTWOOD IR, MARTIN D et al.: Oesophageal symptoms, manometry and histology before and after antireflux surgery: a long-term follow-up study. Gastroenterology (1979) 76:1393–1401.
   PubMed Web of Science ®Google Scholar
• KAHRILAS PJ: Management of GERD: Medical versus Surgical. Seminars in Gastrointestinal Disease (2001) 12:3–15.
   PubMedGoogle Scholar
• ••A critical review of the medical and surgicalmanagement of GERD.
   Google Scholar
• LUNDELL L, MIETTINENP, MYRVOLD HE et al.: Long-term management of gastroesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. Eur. I Gastroenterol Hepatol (2000) 12:879–887.
   PubMedGoogle Scholar
• •The cost-effectiveness of long-term GERD management: PPI versus surgery.
   Google Scholar
• KADIRKAMANATHAN SS, EVANS DF, GONG F et al: Antireflux operations at flexible endoscopy using endoluminal stitching techniques: an experimental study. Gastrointest. Enclose. (1996) 44:133–143.
   PubMed Web of Science ®Google Scholar
• SWAIN CP: Endoscopic suturing. Bailliere's Clin. Gastroenterol (1999) 13:97–108.
   PubMedGoogle Scholar
• MARTINEZ-SERNA T, DAVIS RE, MASON R et al.: Endoscopic valvuloplasty for GERD. Gastrointest. Enclose. (2000) 52:663–670.
   PubMed Web of Science ®Google Scholar
• CASTELL DO: Medical, surgical, and endoscopic treatment of gastroesophageal reflux disease and Barrett's oesophagus. Clin. Gastroenterol (2001) 33:262–266.
   Google Scholar
• ••An overview of the different therapeuticoptions for GERD.
   Google Scholar
• MITTAL RK, BALABAN DH: The esophagogastric junction. N Engl. I Med. (1997) 336:924–932.
   PubMed Web of Science ®Google Scholar
• ••A review of the physiology of theoesophagogastric junction.
   Google Scholar
• HOLLOWAY RH, DENT J: Medical treatment of gastroesophageal reflux disease - beyond the proton pump inhibitors. DV. Dis. (2000) 18:7–13.
   Google Scholar
• VAN HERWAARDEN MA, SAMSON M, SMOUTH AJ: Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations. Gastroenterology (2000) 119:1439–1446.
   PubMed Web of Science ®Google Scholar
• MITTAL RK, HOLLOWAY R, DENT J: Effect of atropine on the frequency of reflux and transient lower oesophageal sphincter relaxation in normal subjects. Gastroenterology (1995) 109:1547–1554.
   PubMed Web of Science ®Google Scholar
• LIDUM I, HEBBARD GS, HOLLOWAY RH et al.: Effect of atropine on proximal gastric motor and sensory function in normal subiects. Gut (2000) 47:30–36.
   PubMedGoogle Scholar
• PENAGINI R, BIANCHI PA: Effect of morphine on gastroesophageal reflux and transient lower oesophageal sphincter relaxation. Gastroenterology (1997) 113:409–414.
   PubMed Web of Science ®Google Scholar
• CIAVE P, GONZALEZ A, MORENO A et al: Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors. Gastroenterology (1998) 115:597–604.
   PubMedGoogle Scholar
• BOULANT J, MATHIEU S, D'AMATO M et al.: Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distention in humans. Gut (1997) 40:575–581.
   Google Scholar
• ZERBIB F, BRULEY DES VARANNES S, SCARPIGNATO Cet al.: Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans. Arn J Physiol (1998) 275:G1266–G1273.
   Google Scholar
• BOECKXSTAENS GE, HIRSCH DP, FAKHRY N et al.: Involvement of cholecystokinin-A receptors in transient lower oesophageal sphincter relaxations triggered by gastric distention. Am. Gastroenterol (1998) 91:1823–1828.
   Google Scholar
• LUIKING YC, WEUSTEN BL, PORTINCASA P et al.: Effects of long-term oral L-arginine on oesophageal motility and gallbladder dynamics in healthy humans. Am. Physic] (1998) 274:G984–G991.
   Google Scholar
• BOULANT J, FIORAMONTI J, DPOIGNY M et al: Cholecystokinin and nitric oxide in transient lower oesophageal sphincter relaxation to gastric distension in dogs. Gastroenterology(1994) 107:1059–66.
   PubMed Web of Science ®Google Scholar
• HIRSCH DP, HOLLOWAY RH, TYTGAT GNJ et al.: Involvement of nitric oxide in human transient lower oesophageal sphincter relaxations and oesophageal primary peristalsis. Gastroenterology (1998) 115:1374–1380.
   PubMed Web of Science ®Google Scholar
• ••The role of NO in the neural control of LESfunction and oesophageal motility.
   Google Scholar
• SYKES RM, SPYER KM, IZZO PN: Demonstration of glutamate immunoreactivity in vagal sensory afferents in the nucleus tractus solitarius of the rat. Brain Res. (1997) 762:1–11.
   PubMed Web of Science ®Google Scholar
• GUNSHEFSKI LA, RIFLEY WJ, SLATTERY DW et al.: Somatostatin stimulation of the normal oesophagus. Am. J. Surg. (1992) 163:59–62.
   PubMed Web of Science ®Google Scholar
• WISEMAN LR, FAULDS D: Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs (1994) 47:116–152.
   Google Scholar
• KAHRILAS PJ, QUIGLEY MM, CASTELL DO et al: The effects of tegaserod (HTF) 919) on oesophageal acid exposure in gastro-oesophageal reflux disease. Aliment. Pharmacol Ther. (2000) 14:1503–1509.
   PubMed Web of Science ®Google Scholar
• •A new drug for the treatment of GERD.
   Google Scholar
• BROOKS PA, GLAUM SR, MILER RJ et al.: The actions of baclofen on neurons and synaptic transmission in the nucleus tractus solitarii of the rat in vitro. I Physiol (1992) 457:115–129.
   PubMedGoogle Scholar
• BLACKSHAW LA, STAUNTON E, LEHMANN Aet Inhibition of transient
   Google Scholar
• •• lower sphincter relaxations in ferret by GABA receptor agonists. Am. j Physic] (1999) 277:G867–874.
   Google Scholar
• LIDUMS I, LEHMANN A, CHECKLIN H et al.: Control of transient lower oesophageal sphincter relaxations and reflux by the GABA agonist baclofen in normal subjects. Gastroenterology (2000) 118:7–13.
   PubMed Web of Science ®Google Scholar
• ZHANG Q, LEHMAN A, RIGDA R et al: Control of transient lower oesophageal sphincter relaxations and reflux by the GABAB agonist baclofen in patients with gastroesophageal reflux disease. Gut (2002) 50:19–24.
   PubMed Web of Science ®Google Scholar
• ••A new potential treatment for GERD.
   Google Scholar